探索四二丁胺治疗心力衰竭的治疗潜力,并保留喷射分数:前进的道路
Weiyi Xia1, Miao Zhang2, Chang Liu3
1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China.
Life sciences
|March 27, 2024
概括
保存喷射分数 (HFpEF) 的心力衰竭是一个主要的未满足的医疗需求. 水生物素 (BH4) 通过解决炎症和线粒体功能障碍,在治疗HFpEF方面表现有前途.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭影响许多患者,导致高发病率和死亡率.
- 目前对HFpEF的治疗方法有限,这突出了未满足的医疗需求.
- 系统性炎症,氧化应激和线粒体功能障碍是HFpEF的关键病理机制.
研究的目的:
- 审查针对心血管疾病的氧化 (NO) 途径的当前治疗方法,包括HFpEF.
- 讨论四水生物素 (BH4) 作为HFpEF新型治疗剂的潜力.
- 提出新的证据支持BH4在管理HFpEF中的作用.
主要方法:
- 对HFpEF病理生理学和治疗的临床和基本研究的文献综述.
- 对心血管疾病的现有治疗策略的分析,包括NO捐赠者,sGC激活剂,PDE抑制剂和SGLT2抑制剂.
- 评估BH4的生化功能及其在心血管健康中的新兴作用.
主要成果:
- 现有的HFpEF治疗方法存在局限性.
- BH4显示出对抗HFpEF关键病理机制的潜力,包括炎症和线粒体功能障碍.
- BH4可能为HFpEF治疗提供一种新的药理方法.
结论:
- 由于治疗选择有限,HFpEF仍然是一个重大的临床挑战.
- 由于BH4的多方面的生物作用,它被认为是HFpEF治疗的有希望的候选者.
- 需要进一步研究BH4在HFpEF中的疗效和安全性.
相关概念视频
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Heart Failure Drugs: Inotropic Agents
578
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
578
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
159
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
159
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370